Gonococcal Urethritis Treatment Guidelines
Primary Treatment Regimen
- The Centers for Disease Control and Prevention recommends cefixime 400 mg orally as a single dose plus azithromycin 1 g orally, with mandatory test-of-cure in 1 week, as an alternative regimen for patients unable to receive ceftriaxone 1
Alternative Regimens
- For patients with severe cephalosporin allergy, azithromycin 2 g orally as a single dose is recommended, with mandatory test-of-cure in 1 week, although it causes significant gastrointestinal distress 2, 3
- Spectinomycin 2 g IM single dose is another alternative for cephalosporin-allergic patients, with a 96.7% cure rate for urogenital infections, but limited availability in many regions 2, 3
Critical Management Components
- The Centers for Disease Control and Prevention recommends that all sexual partners from the preceding 60 days must be evaluated and treated for both gonorrhea and chlamydia 2, 3, 1
- Patients and partners must abstain from sexual intercourse until therapy is completed and symptoms have resolved 2, 1
Special Populations
- Pregnant women should receive ceftriaxone, with the same dose as non-pregnant patients, and avoid quinolones and tetracyclines completely 2
- HIV-infected patients should use the same treatment regimen as HIV-negative patients, as treatment is particularly vital to prevent increased HIV shedding and transmission risk 2, 1
Critical Pitfalls to Avoid
- The Centers for Disease Control and Prevention recommends against using quinolones as first-line therapy due to widespread resistance 2, 3
- Azithromycin 1 g as monotherapy should not be used for gonorrhea, as it cures only 93% of infections 2, 3
- Partner treatment should not be skipped, as this is the primary cause of apparent treatment failure 2